DONATE

NJHRC

NJHRC applauds FDA naloxone decision, calls for more affordable over-the-counter options

by

Yesterday, the US Food and Drug Administration (FDA) approved the first ever over-the-counter form of naloxone. This approval applies only to the 4mg nasal spray manufactured by Emergent Biosolutions, which is significantly more expensive than other more affordable versions, including intramuscular naloxone. In response, New Jersey Harm Reduction Coalition (NJHRC) released the following statement.Jenna Mellor, … Read more

“Just Say No” to Fentanyl Penalty Upgrades

by

“Just Say No” to Fentanyl Penalty Upgrades Increasing fentanyl penalties will exacerbate the overdose crisis, do nothing to reduce the drug supply or demand, and deepen racial injustice fueled by the War on Drugs. It is time for New Jersey policymakers to “just say no” to the drug war and reject S-3096 and S-3325.New Jersey … Read more

Harm reduction advocates praise Naloxone365 announcement

by

Earlier today in New Jersey’s State of the State address, Governor Murphy announced the launch of Naloxone365. This new program will enable every pharmacy in New Jersey to provide 4mg nasal spray naloxone anonymously and for free to any resident who requests it, at any time throughout the year. When the Murphy Administration started the … Read more

New Report – $1.0 billion in annual healthcare costs from preventable injection-related infections in New Jersey

by

Without access to harm reduction supplies, New Jerseyans who inject drugs are at risk of infection, hospitalization, and preventable death, according to a new report released today by New Jersey Harm Reduction Coalition (NJHRC). The report, Preventable Harms: Injection Drug-Use Related Infections in New Jersey, reviews data from the Healthcare Cost and Utilization Project and … Read more